CEO & Co-Founder

Long history of firsts at the cutting edge of medical research. First graduate of Harvard Medical School’s regenerative medicine PhD program. Developer of the world’s first disease induced stem cell line. Creator of the world’s first lab grown gut model capable of being engineered at scale during her time at MIT. Dr. Arora now leads BioDaVinci’s work in triggering cells’ inherent regenerative processes through controlled modulation of bioelectric signaling.

CSO & Co-Founder

Developer of cutting edge method for controlled modulation of bioelectric signaling with drugs. With training at the intersection of organic chemistry, ligands-receptor interactions, and biosensing, Dr. Arora brings a unique perspective to the challenges of nuanced modulation of the cell level control units of bioelectricity. Dr. Arora previously founded a life science consulting firm focused on drug discovery.

CTO & Co-Founder

Neuroscientist researcher turned AI engineer, Dr. Ritter is uniquely positioned with deep understanding of both the functioning of human biology at the cellular level and cutting edge natural AI tools. He previously led AI transformation at Forrester Research turning 70 years of research content into searchable and actionable insights.

Founding Advisor

30 year veteran of Silicon Valley entrepreneurship with multiple founding and C-suite roles spanning technology, health, and venture. Chen brings to BioDaVinci his first hand experience with the power of both technology to transform industries and bioelectric signaling for regeneration.

Natural Language Processing Engineer

Data Scientist

Molecular Pharmacologist

Medicinal Chemist

Machine Learning Engineer

Software Engineer

Bioinformatician

Pharma Partnerships

VP of Partnerships at Scientist.com, the world’s largest platform for medical research.  Long has been influential in building Scientist’s book of business that includes 20 of the world's 30 largest pharmaceutical companies and over 80 biotech companies.

AI & Machine Learning

Machine learning expert with previous leadership roles at Google and Deep Genomics (AI drug development).  He is the founder of Move37 Labs, an AI consulting firm empowering tech bio, med tech, and other impact-driven organizations to solve critical challenges through cutting-edge artificial intelligence by translating complex data into actionable insights and tangible positive outcomes.

Technology Platforms

40 year veteran of technology platform development and implementation.  His prior roles include Director of Engineering at Oracle and CTO at InnoCentive, a spin out of Eli Lilly focused on solving hard problems with science and technology.  He currently serves as Senior Advisor at Boston Consulting Group where he specializes in use of technology to create competitive advantage.

Startup Scaling

Experienced startup advisor and investor.  Schechter was a member of the Band of Angels for 15 years, former mentor for Standford’s startup accelerator StartX, and co-founded SVBIG an organization that supports creation of new technology ventures through mentorship.  Previously, Schechter spent 17 years at Intel Corporation where he held a variety of technical and marketing roles.